These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6977637)

  • 1. Analysis of oral suspensions containing sulfonamides in combination with erythromycin ethylsuccinate.
    Elrod L; Cox RD; Plasz AC
    J Pharm Sci; 1982 Feb; 71(2):161-6. PubMed ID: 6977637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic assay of erythromycin and its esters using electrochemical detection.
    Croteau D; Vallée F; Bergeron MG; LeBel M
    J Chromatogr; 1987 Aug; 419():205-12. PubMed ID: 3499443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorimetric determination of erythromycin and erythromycin ethylsuccinate in serum by a high-performance liquid chromatographic post-column, on-stream derivatization and extraction method.
    Tsuji K
    J Chromatogr; 1978 Oct; 158():337-48. PubMed ID: 721936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of erythromycin and related substances in enteric-coated tablet formulations by reversed-phase liquid chromatography.
    Wardrop J; Ficker D; Franklin S; Gorski RJ
    J Pharm Sci; 2000 Sep; 89(9):1097-105. PubMed ID: 10944374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.
    Croteau D; Bergeron MG; LeBel M
    Antimicrob Agents Chemother; 1988 Apr; 32(4):561-5. PubMed ID: 3259856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stability of tablet formulation containing erythromycin ethylsuccinate and demeclocycline hydrochloride].
    Giovinazzo C; Puglisi G; Milazzo L; Caruso A; Mazzone G; Bernardini A
    Boll Chim Farm; 1983 Feb; 122(2):109-17. PubMed ID: 6409133
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of erythromycin ethylsuccinate by liquid chromatography.
    Cachet T; Lannoo P; Paesen J; Janssen G; Hoogmartens J
    J Chromatogr; 1992 May; 600(1):99-108. PubMed ID: 1400845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].
    Potthast H; Schug B; Elze M; Schwerdtle R; Blume H
    Pharmazie; 1995 Jan; 50(1):56-60. PubMed ID: 7886126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
    Yakatan GJ; Rasmussen CE; Feis PJ; Wallen S
    J Clin Pharmacol; 1985; 25(1):36-42. PubMed ID: 3871797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous determination of erythromycin ethylsuccinate and its metabolite erythromycin in human plasma using liquid chromatography-electrospray ionization mass spectrometry for clinical study.
    Gu Y; Wang G; Sun J
    J Pharm Biomed Anal; 2006 Feb; 40(3):737-43. PubMed ID: 16376051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
    Shanson DC; Tidbury P; McNabb WR; Tadayon M
    J Antimicrob Chemother; 1984 Aug; 14(2):157-63. PubMed ID: 6334070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
    Patamasucon P; Kaojarern S; Kusmiesz H; Nelson JD
    Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms.
    Morgan DK; Brown DM; Rotsch TD; Plasz AC
    J Pharm Biomed Anal; 1991; 9(3):261-9. PubMed ID: 1831386
    [No Abstract]   [Full Text] [Related]  

  • 14. Stability-indicating sulfa drug analysis using high-performance liquid chromatography.
    Umagat H; McGarry PF; Tscherne RJ
    J Pharm Sci; 1979 Jul; 68(7):922-4. PubMed ID: 458618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals.
    Lakritz J; Wilson WD; Marsh AE; Mihalyi JE
    Vet Ther; 2002; 3(2):189-95. PubMed ID: 19750750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin/sulfisoxazole treatment for otitis media.
    Sasso SC
    MCN Am J Matern Child Nurs; 1983; 8(3):193. PubMed ID: 6405116
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized, double blind comparison of brand and generic antibiotic suspensions: I. A study of taste in adults.
    Samulak KM; El-Chaar GM; Rubin LG
    Pediatr Infect Dis J; 1996 Jan; 15(1):14-17. PubMed ID: 8684870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple thin-layer chromatographic identification procedure for erythromycin base, stearate, estolate and ethylsuccinate.
    Vilim A; LeBelle MJ; Wilson WL; Graham KC
    J Chromatogr; 1977 Mar; 133(1):239-44. PubMed ID: 838805
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythromycin ethylsuccinate-sulfamethoxazole mixture vs. amoxicillin for acute otitis media.
    Kaleida PH
    Pediatr Infect Dis J; 1988 May; 7(5):370. PubMed ID: 3260024
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of 2'-acetyl erythromycin and erythromycin in human tonsil tissue by HPLC with coulometric detection.
    Haataja H; Kokkonen P
    J Antimicrob Chemother; 1988 Jun; 21 Suppl D():67-72. PubMed ID: 3391877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.